A pharma investor client joined a European animal health company and asked Alacrita to conduct a strategic review, in the light of urgent business needs. The entire sector had been through a difficult period during the COVID pandemic and a number of industry participants continued to face challenges in the aftermath and in the evolving agrifood landscape and regulatory frameworks in Europe. An internal team at the company was developing strategic and implementation plans for major changes to the business configuration, but the board of directors wanted an independent expert view. After a multi-stage briefing, Alacrita prepared a proposal to assess the company's current condition and evaluate a range of tactical and strategic options, and then present its recommendations to the board.
Alacrita put together a team that included two previous animal health industry executives, along with manufacturing and supply chain experts, who engaged with the client through a series of data requests and structured interviews with select senior managers only, given the sensitive nature of the situation.
The Alacrita project team conducted a deep strategic audit of the business and delved into the operational condition of the company, as deeply as was appropriate in the circumstances. We presented an initial interim report with our conclusions regarding the challenges facing the business and the viability of high-level strategic options. After deeper analysis, including a survey of the market dynamics and competitive environment, we presented a second interim report with defined recommendations for a turnaround strategy for the client's European business unit, over a three-to-five-year period.
The executive summary of the final report was presented to the board, after which the client decided to put on hold the original plans being developed internally, to focus on our team’s recommended actions.
Our consultants provide strategic guidance and technical support in a variety of areas critical for animal health companies seeking to achieve sustainable growth and value creation.